Elevated serum levels of Interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis

IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17–Triggering Cytokine Production and Limiting Th17 Cell Proliferation

(2015) Liang Ye et al.   JOURNAL OF IMMUNOLOGY

Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity

(2015) Bingni Chen et al.   Journal of Translational Medicine

IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury

(2015) Yunbo Yang et al.   KIDNEY INTERNATIONAL

Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss

(2015) Tania N. Crotti et al.   Journal of Immunology Research

RETRACTED: IL-37 reduces inflammatory response after cerebral ischemia and reperfusion injury through down-regulation of pro-inflammatory cytokines

(2014) Faye J. Patel et al.   CYTOKINE

IL-37 Ameliorates the Inflammatory Process in Psoriasis by Suppressing Proinflammatory Cytokine Production

(2014) X. Teng et al.   JOURNAL OF IMMUNOLOGY

A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells

(2014) Siyuan Xia et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Intestinal Expression of the Anti-Inflammatory Interleukin-1 Homologue IL-37 in Pediatric Inflammatory Bowel Disease

(2014) Simon Weidlich et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity

(2014) Liang Ye et al.   Journal of Translational Medicine

Seronegative and seropositive RA: alike but different?

(2014) Sofia Ajeganova et al.   Nature Reviews Rheumatology

Plasma Levels of IL-37 and Correlation with TNF-α, IL-17A, and Disease Activity during DMARD Treatment of Rheumatoid Arthritis

(2014) Ping-Wei Zhao et al.   PLoS One

IL-37 protects against obesity-induced inflammation and insulin resistance

(2014) Dov B. Ballak et al.   Nature Communications

Emerging cell and cytokine targets in rheumatoid arthritis

(2013) Gerd R. Burmester et al.   Nature Reviews Rheumatology

Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells

(2012) Nozomu Sakai et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Bone Loss in Rheumatoid Arthritis: Systemic, Periarticular, and Focal

(2012) Chad Deal   Current Rheumatology Reports

Interleukin-23 as a potential therapeutic target for rheumatoid arthritis

(2011) Chao Rong et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Interleukin 37 expression protects mice from colitis

(2011) E. N. McNamee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-37 is a fundamental inhibitor of innate immunity

(2010) Marcel F Nold et al.   NATURE IMMUNOLOGY

Th17 cytokines and arthritis

(2010) Erik Lubberts   Seminars in Immunopathology

Evidence that cytokines play a role in rheumatoid arthritis

(2008) Fionula M. Brennan et al.   JOURNAL OF CLINICAL INVESTIGATION